Abstract:Objective:
Celiac disease (CD) is a multifactorial immune-mediated enteropathy caused by a response to ingested gluten. The current available treatment for CD is lifelong gluten-free diet (GFD). This study was done to see the effect of GFD on Vitamin D levels and bone mass density in celiac patients.
Methods:
A prospective interventional study on newly diagnosed celiac patients was conducted in the Pediatrics department of a tertiary care teaching institute in 2 stages … Show more
“…In regard to pediatric case, it appears that celiac children, observing a GFD, have dietary trends similar to the corresponding healthy controls, with both celiac and non-celiac subjects having vitamin D intake below reference standards [ 80 , 81 ]. However, in two prospective studies on pediatric celiac patients, after one year or six months of GFD, respectively, a significant increase in vitamin D level was observed, which was associated or not with a decline in PTH levels [ 82 , 83 ]. Similar results were obtained in a cohort of the adult population, where patients not adhering to a GFD had lower vitamin D and BMD values at diagnosis, and higher PTH values than subjects adhering to the diet [ 84 ].…”
Section: The Role Of Vitamin D In Metabolic Syndrome Celiac Disease A...mentioning
Celiac disease is a rising disorder and is becoming frequently diagnosed in recent years. To date, the only available treatment is the gluten-free diet (GFD). The role of gluten on components of metabolic syndrome and on related inflammatory response is still unclear due to controversial results. In recent years, scientific focus on this topic has been growing up, in particular regarding the role of the GFD on glycometabolic parameters and diabetes. In addition, studies on the remaining components showed discordant results, which was likely due to heterogeneous and large celiac disease populations and to the lack of prospective studies. Furthermore, knowledge about the role of the GFD on inflammatory cytokines and the relationship among vitamin D and celiac disease, metabolic syndrome (MS) and GFD is needed. In this narrative review, we provided evidence regarding the role of the GFD on glycometabolic parameters, cholesterol, triglycerides, waist circumference, blood pressure and inflammatory cascade, also evaluating the role of vitamin D, trying to summarize whether this nutritional pattern may be a value-added for subjects with dysmetabolic conditions. Finally, due to the limited findings and very low-certainty evidence, predominantly based on observational studies, the real effects of a GFD on different components of MS, however, are unclear; nevertheless, an improvement in HDL levels has been reported, although data on glycemic levels are discordant.
“…In regard to pediatric case, it appears that celiac children, observing a GFD, have dietary trends similar to the corresponding healthy controls, with both celiac and non-celiac subjects having vitamin D intake below reference standards [ 80 , 81 ]. However, in two prospective studies on pediatric celiac patients, after one year or six months of GFD, respectively, a significant increase in vitamin D level was observed, which was associated or not with a decline in PTH levels [ 82 , 83 ]. Similar results were obtained in a cohort of the adult population, where patients not adhering to a GFD had lower vitamin D and BMD values at diagnosis, and higher PTH values than subjects adhering to the diet [ 84 ].…”
Section: The Role Of Vitamin D In Metabolic Syndrome Celiac Disease A...mentioning
Celiac disease is a rising disorder and is becoming frequently diagnosed in recent years. To date, the only available treatment is the gluten-free diet (GFD). The role of gluten on components of metabolic syndrome and on related inflammatory response is still unclear due to controversial results. In recent years, scientific focus on this topic has been growing up, in particular regarding the role of the GFD on glycometabolic parameters and diabetes. In addition, studies on the remaining components showed discordant results, which was likely due to heterogeneous and large celiac disease populations and to the lack of prospective studies. Furthermore, knowledge about the role of the GFD on inflammatory cytokines and the relationship among vitamin D and celiac disease, metabolic syndrome (MS) and GFD is needed. In this narrative review, we provided evidence regarding the role of the GFD on glycometabolic parameters, cholesterol, triglycerides, waist circumference, blood pressure and inflammatory cascade, also evaluating the role of vitamin D, trying to summarize whether this nutritional pattern may be a value-added for subjects with dysmetabolic conditions. Finally, due to the limited findings and very low-certainty evidence, predominantly based on observational studies, the real effects of a GFD on different components of MS, however, are unclear; nevertheless, an improvement in HDL levels has been reported, although data on glycemic levels are discordant.
“…Eleven articles reported the numbers of patients and controls with VitD de ciency [8,14,18,22,25,26,28,30,33,35,43] , and eight showed that 25(OH)D de ciency was more prevalent in CD patients [8,18,25,26,28,33,35,43] . In addition, ten articles reported changes in 25(OH)D levels before and after administering a GFD in patients with CD [17,23,24,28,32,[37][38][39][40][41] ,…”
Background: The relationship between vitamin D (VitD) levels and pediatric celiac disease (CD) remains controversial. In this study, we conducted a systematic review and meta‐analysis to examine the relationship between VitD and pediatric CD.
Methods: We screened relevant studies from PubMed, EMBASE and Web of Science published in English from January 1, 2000, to August 1, 2023. The included studies were assessed according to the STROBE checklist. Heterogeneity was quantified by Cochran’s Q test and the I2 statistic. Publication bias was estimated by Begg’s test and Egger test. Meta‐regression was used to detect potential sources of heterogeneity.
Results: A total of 26 studies were included in the meta-analysis. Average 25(OH)D levels, as the main form of VitD, there was significant difference in CD patients and healthy controls (weighted mean difference (WMD) = −5.77, 95% confidence interval (CI) = [−10.86, − 0.69] nmol/L). Meanwhile, there was significant difference in the incidence of 25(OH)D deficiency between CD patients and healthy controls (odds ratio 2.20, 95% CI= [1.19, 4.08]). Ten articles reported changes in 25(OH)D levels before and after administering a GFD in patients with CD, while the result of this study revealed no change in 25(OH)D levels in CD patients after a gluten-free diet (GFD) compared to controls (WMD = −2.22, 95% CI = [−7.25, 2.81] nmol/L).
Conclusions: VitD levels in pediatric CD patients were lower than healthy controls, and 25(OH)D deficiency was more prevalent in CD patients. We found no change in 25(OH)D levels in CD patients after GFD compared to controls, which inconsistent with previous research. Further well-designed, longitudinal, prospective cohort studies focusing on the role of VitD in the pathogenesis of CD are therefore needed.
“…However, the diet-related increase may not be sufficient to normalize VD serum levels. Verma et al, studying a group of children with newly onset CD, reported that in those with VD insufficiency (serum concentration 12–20 ng/mL) 6 months of GFD were associated with a significant increase of VD serum levels (from baseline 14.8 ± 5.39 ng/mL to 18.22 ± 5.67), but in several of them, VD levels remained in the abnormal range [ 81 ]. This seems to confirm the importance of adequate VD level monitoring in patients with CD, both at onset and during GFD.…”
Section: Vitamin D and Celiac Diseasementioning
confidence: 99%
“…However, the optimal amount of VD supplementation to reach normal VD levels in CD patients is not established. Administration of patients with VD deficiency (<12 ng/mL) who, together with the GFD, were given 60,000 IU of VD per week during the first 3 months of treatment showed a significant increase in VD serum levels (from 9.45 ± 0.45 ng/mL to 13.53 ± 1.52 ng/mL), but no case reached normal VD values [ 81 ]. However, regardless of VD levels at onset or during GFD, most of the experts recommended that VD serum level monitoring be systematically performed in all subjects with CD, regardless of age, and VD deficiency, when documented, be corrected using the suggested dosage.…”
Vitamin D (VD) is a pro-hormone that has long been known as a key regulator of calcium homeostasis and bone health in both children and adults. In recent years, studies have shown that VD may exert many extra-skeletal functions, mainly through a relevant modulation of the innate and adaptive immune system. This has suggested that VD could play a fundamental role in conditioning development, clinical course, and treatment of several autoimmune disorders, including celiac disease (CD) and inflammatory bowel diseases (IBDs). The main aim of this review is to evaluate the relationships between VD, CD, and IBDs. Literature analysis showed a potential impact of VD on CD and IBDs can be reasonably assumed based on the well-documented in vitro and in vivo VD activities on the gastrointestinal tract and the immune system. The evidence that VD can preserve intestinal mucosa from chemical and immunological damage and that VD modulation of the immune system functions can contrast the mechanisms that lead to the intestinal modifications characteristic of gastrointestinal autoimmune diseases has suggested that VD could play a role in controlling both the development and the course of CD and IBDs. Administration of VD in already diagnosed CD and IBD cases has not always significantly modified disease course. However, despite these relevant problems, most of the experts recommend monitoring of VD levels in patients with CD and IBDs and administration of supplements in patients with hypovitaminosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.